Article Sidebar

Download
PDF

Main Article Content

Abstract

RÉSUMÉ
La maladie veineuse thromboembolique (MVTE) regroupe deux entités cliniques principales : la thrombose veineuse profonde (TVP) et l’embolie pulmonaire (EP). Comme facteurs de risque, on dénombre entre autres : l’âge, la chirurgie, le cancer, les infections, une immobilisation prolongée, la grossesse, le déficit en protéine C, protéine S. Nous rapportons ici un cas de thrombose veineuse humérale suite à une néoplasie hypophysaire et un cas d’embolie pulmonaire sur déficit en protéine S.


ABSTRACT
Venous thromboembolic disease (VTE) includes two main clinical entities: deep vein thrombosis (DVT) and pulmonary embolism (PE). Venous thromboembolic risk factors include, among others: age, surgery, cancer, infections, prolonged immobilization, pregnancy, C protein and S protein deficiencies. We report a case of humeral venous thrombosis in a history of pituitary neoplasia and a case of pulmonary embolism due to S protein deficiency.

Keywords

Thrombose humérale, embolie pulmonaire, déficit protéine S, Yaoundé-Cameroun

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
Nganou-Gnindjio, C.-N. ., Magny Tiam, E. ., Mbede, M. ., Ananfack, E. G. ., Kuate, L. ., Ndobo-Koe, D. V. ., Nyinyikua Nsangou, T. ., Koulsoumi, O. ., Djantio Noundou, H. ., Ntep, M. ., & Tayou, C. . (2022). Thrombose Veineuse Profonde Humérale et Embolie Pulmonaire sur Déficit en Protéine S: à Propos de deux Cas . HEALTH SCIENCES AND DISEASE, 23(4). https://doi.org/10.5281/hsd.v23i4.3569
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Hong J, Lee JH, Lee JY, Lee JO, Choi WI, Ahn S, et al. Prominent seasonal variation in pulmonary embolism than deep vein thrombosis incidence: a Korean venous thrombosis epidemiology study. Korean J Intern Med. 1 Mai 2020;35(3):682 91.
  2. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). European Heart Journal. 21 Jan 2020;41(4):543 60.
  3. Pessinaba S, Atti YD, Baragou S, Pio M, Afassinou Y, Kpélafia M, et al. L’embolie pulmonaire au centre hospitalier universitaire Campus de Lomé (Togo): étude rétrospective à propos de 51 cas. Pan Afr Med J. 18 Juin 2017;27.
  4. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. Avr 2010;38(4 Suppl):S495-501.
  5. Alhassan S, Pelinescu A, Gandhi V, Naddour M, Singh AC, Bihler E. Clinical Presentation and Risk Factors of Venous Thromboembolic Disease. Crit Care Nurs Q. Sept 2017;40(3):201 9.
  6. Bruni FK. Venous thromboembolism: An overview. J Vasc Nurs. Sept 2015;33(3):95.
  7. MunozFJ, MismettiP, PoggioR, . Clinical outcome of patients with upper-extremity deep vein thrombosis : Results from the RIETE Registry. Chest 2008;133:143–8.
  8. JoffeHV, KucherN, TapsonVF, . Upper-extremity deep vein thrombosis : A prospective registry of 592 patients. Circulation 2004;110:1605–11.
  9. KhoranaAA, McCraeKR. Risk stratification strategies for cancer-associated thrombosis : An update. Thromb Res 2014;133(Suppl. 2):S35–8.
  10. ChanWS, GinsbergJS. A review of upper extremity deep vein thrombosis in pregnancy : Unmasking the «ART» behind the clot. J Thromb Haemost 2006;4:1673–7.
  11. HeronE, LozinguezO, Alhenc-GelasM, . Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med 2000;160:382–6.

Most read articles by the same author(s)

1 2 > >>